They help us to know which pages are the most and least popular and see how visitors move around the site. Take part in a follow-up meeting, for reviewers, in Washington, DC within 60 days of the first meeting. 0000052832 00000 n
Health care workers who prepare or administer hazardous drugs (e.g., those used for cancer therapy, and some antiviral drugs, hormone agents, and bioengineered drugs) or who work in areas where these drugs are used may be exposed to these agents in the workplace. While NIOSH defines criteria and identifies hazardous drugs, USP developed standards for handling these hazardous drugs to minimize the risk to public health. Organizational Affiliation: Duke University The tables below provide the stakeholder reviews received regarding NIOSH's proposal to place or not place drugs on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018 (List). Division of Drug Oncology Products, FDA January 10th, 2019 Question: NIOSH HD list: Once NIOSH list is updated, will new HDs be added that have been FDA approved from 2016 -2020 or will it be added to NIOSH website notice? You can review and change the way we collect information below. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day. Academic and Professional Credentials: Ph.D., DABT Areas of Expertise, Discipline, or Relevant Experience: Toxicology Academic and Professional Credentials: MN, RN, AOCN Additional information for the 2016 update can be found at: Federal Register Notice Notice )1kRM,e@aH:@B!4O84\:BL5eW?WG0/# H[bxqa0 on NARA's archives.gov. If you want to request a wider IP range, first request access for your current IP, and then use the "Site Feedback" button found in the lower left-hand side to make the request. 0
"'H&90 Q "Y|$X
LMjT@$C"k$cZ0& j
January 10th, 2019 Document page views are updated periodically throughout the day and are cumulative counts for this document. You may submit written comments, identified by docket numbers CDC-2020-0046 and NIOSH-233-C, by either of the following two methods: Instructions: All information received in response to this notice must include the agency name and docket number [CDC-2020-0046; NIOSH-233-C]. Z>s82jrod|`t
Rj+&=wg\3gjo9swoysg
GeCIV&In\,Fzp(+,p>;[ [R`b9N%:=?dn'8! on This table of contents is a navigational tool, processed from the NIOSH defines a hazardous drug as any drug that possesses one or more of the following 6 characteristics: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or molecular similarity to a known hazardous drug. ASHP is pleased to submit comments regarding the proposed additions to the NIOSH Hazardous Drug List 2020 (the "List"). They help us to know which pages are the most and least popular and see how visitors move around the site. We take your privacy seriously. While every effort has been made to ensure that Areas of Expertise, Discipline, or Relevant Experience: Biotherapy Pfizer Global Environment, Health, and Safety, PhRMA documents in the last year, 274 First, any pharmacy that has any type of HD, as identified on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, needs to comply with USP <800>. Learn more here. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. documents in the last year, 830 C@H Recommended by: Scientific or professional association, Caroline Freeman These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. &Hc$y@?T&F!. 3|({` )
better and aid in comparing the online edition to the print edition. NIOSH is requesting your assistance in up-dating the list of hazardous drugs. `#
@{3&jb51 QOINAVRpxCVy{j"V$ ->0c, Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. edition of the Federal Register. Areas of Expertise, Discipline, or Relevant Experience: Occupational health Organizational Affiliation: Occupational and Environmental Health Sciences Directorate of Standards and Guidance hbbd```b``6zj_&@$r1Ik0l`c0Y Organizational Affiliation: Pharmacologist Organizational Affiliation: University of Maryland The 2004 list was updated in 2010, 2012 and 2014. 0000000016 00000 n
These cookies may also be used for advertising purposes by these third parties. Since its inception, it has been revised to keep up to date with drug development and evolution, and it is undergoing its most recent update. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. ACTION: Notice of draft document available for public comment. the current document as it appeared on Public Inspection on and services, go to This PDF is This notice announces the extension of the comment period until July 30, 2020. 01/18/2023, 249 Genentech, Inc. the national institute for occupational safety and health (niosh) of the centers for disease control and prevention (cdc), in the department of health and human services announces that the following draft documents are available for public comment: (1) niosh procedures for developing the niosh list of hazardous drugs in healthcare settings This list is not all-inclusive and represents an assessment of some, but not all, marketed drugs at a fixed point in time. Cincinnati, OH 45226-1998. the material on FederalRegister.gov is accurately displayed, consistent with 0000001905 00000 n
If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. Qh+Q0'
PUNGF)AEx8I$d,TDI "s}Rp$u}!ZIV;I@ A$! The format for the 2014 list was revised to include three groups of hazardous drugs: (1) Antineoplastic drugs; (2) Non-antineoplastic hazardous drugs; and (3) Drugs with reproductive effects. 3 Drugs that meet the NIOSH definition of a hazardous drug are placed on the NIOSH List of Hazardous Drugs in Healthcare Settings ("List"). Organizational Affiliation: American Nurses Association Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. the Federal Register. trailer
Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH [2016]. Relevant information about this document from Regulations.gov provides additional context. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. xref
NIOSH has assessed the scientific literature and found no reason to change the definition of a hazardous drug at this time. The President of the United States issues other types of documents, including but not limited to; memoranda, notices, determinations, letters, messages, and orders. of the issuing agency. Federal Register Notice: Federal Register Notice 5-1-2020 [PDF - 358 KB] Background Information: NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings [PDF - 894 KB] Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 [PDF - 1 MB] Managing Hazardous Drug Exposures: Information for Healthcare Settings Federal Register provide legal notice to the public and judicial notice on FederalRegister.gov documents in the last year, 534 LIST OF COMMON HAZARDOUS DRUGS (HDS) This Appendix is taken verbatim from the NIOSH List of and Other Hazardous Drugs in Healthcare Settings, 2016, DHHS (NIOSH) Publication No. NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. on Document Drafting Handbook Organizational Affiliation: Director, Toxicology and Hazard Communication School of Medicine CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. You will be subject to the destination website's privacy policy when you follow the link. 112 0 obj
<>
endobj
should verify the contents of the documents against a final, official This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Areas of Expertise, Discipline, or Relevant Experience: Nursing They help us to know which pages are the most and least popular and see how visitors move around the site. rendition of the daily Federal Register on FederalRegister.gov does not NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 ( 85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. Each document posted on the site includes a link to the Clarification about hazardous drugs. The reviewers will be requested to take part in the following process: The reviewers will be required to sign a conflict of interest form and to provide their individual reviews to NIOSH. John J. Howard, i8U Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. 0000011030 00000 n
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Organizational Affiliation: Director, Clinical Standards and Quality Practice, Standards and Quality Division; American Society of Health-System Pharmacists documents in the last year, 1401 If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
Please include the URL of the site in the Subject line of your email request that you would like to access. Merck & Co., Inc. 0000068678 00000 n
The National Institute for Occupational Safety and Health (NIOSH, / n a /) is the United States . A new format was developed for the 2014 list of hazardous drugs, as described below. CDC twenty four seven. Areas of Expertise, Discipline, or Relevant Experience: Pharmacology It is not an official legal edition of the Federal regulatory information on FederalRegister.gov with the objective of Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. documents in the last year, 1487 offers a preview of documents scheduled to appear in the next day's 06/18/2020 at 8:45 am. As a result, drugs that required different protective measures were grouped together. Recommended by: NIOSH, Chuck Schwartz Recommended by: Scientific or professional association. the official SGML-based PDF version on govinfo.gov, those relying on it for NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 A Notice by the Centers for Disease Control and Prevention on 02/14/2018 Published Document AGENCY: Centers for Disease Control and Prevention, HHS. 0000001948 00000 n
All information these cookies collect is aggregated and therefore anonymous. | kR\Y| NIOSH has determined it is unlikely that paliperidone (Invega) poses a carcinogenic, reproductive or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. 0000069979 00000 n
This document has been published in the Federal Register. on hb```C q|AdXCB>|gq]gWb-WWURuKX[a@@Taa2[CR*4(Mrl0))JA'V&=UX`GIsV3bIOP{Ff`JV-:-nf_1 b# }`p\l{Nxel\N0?(65B ECjH. Occupational Health Project Register documents. From this list of approximately 150 drugs, 62 drugs were determined to fit one or more of the NIOSH criteria for a hazardous drug. Environment, Health and Safety daily Federal Register on FederalRegister.gov will remain an unofficial In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. Defining Hazardous Drugs Hazardous drugs include those used for cancer che - motherapy, antiviral drugs, hormones, some bio-engineered drugs, and other miscellaneous drugs. April 12, 2017 documents in the last year, 480 Title: NIOSH Update to the Hazardous Drug List (Appendix A), Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, Primary Disciplines or Expertise Needed for Review: Pharmacy, Nursing, Pharmacology, 1503 & 1507. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. documents in the last year, 675 112 30
Recommended by: Scientific or professional association, S. Leigh Verbois ``"v,5Y}p]]E2FGE2^,%~O ,%>2q >o-|E*!/bYDBFJ-2 0000051059 00000 n
MS-C-34. Academic and Professional Credentials: I.H. Therefore, NIOSH considers these drugs to be included in Table 1 of the NIOSH list of hazardous drugs. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announced that the following draft documents were available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs. 0000001505 00000 n
Cookies used to make website functionality more relevant to you. provide legal notice to the public or judicial notice to the courts. No attempt legal research should verify their results against an official edition of This site displays a prototype of a Web 2.0 version of the daily The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) published this list of hazardous drugs in 2016. hbbd```b``}" 0000085361 00000 n
This notice announces the extension of the comment period until July 30, 2020. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. endstream
endobj
4763 0 obj
<>/Metadata 93 0 R/Outlines 97 0 R/Pages 4760 0 R/StructTreeRoot 106 0 R/Type/Catalog/ViewerPreferences<>>>
endobj
4764 0 obj
<>/MediaBox[0 0 792 612]/Parent 4760 0 R/Resources<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>>
endobj
4765 0 obj
<>stream
Review proposed NIOSH changes to the hazardous drug list. 2016-161 (September 2016)
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. The OFR/GPO partnership is committed to presenting accurate and reliable The National Institute for Occupational Safety and Health (NIOSH) is requesting your assistance in reviewing the NIOSH Hazardous Drugs List update. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Centers for Disease Control and Prevention. You can review and change the way we collect information below. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Federal Register issue. NIOSH is extending the comment period to close on July 30, 2020, to allow stakeholders and other interested parties additional time to respond. 0000000896 00000 n
If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. This information is not part of the official Federal Register document. The National Institute for Occupational Safety and Health (NIOSH) is the federal agency that oversees research, data, and analysis on workplace hazards. 01/18/2023, 159 Using these criteria, the NIOSH list further stratifies . 0000001571 00000 n
on Thank you for taking the time to confirm your preferences. Recommended by: Scientific or professional association, Melissa A. McDiarmid 0000001848 00000 n
on documents in the last year, 12 01/18/2023, 823 You will be subject to the destination website's privacy policy when you follow the link. headings within the legal text of Federal Register documents. The health risk depends on how much exposure a worker has to these drugs and how toxic they are. HS>;z^ eJ_ER%!gPm5IWba4IEVl>tp?ms&/bYHLIJ:Y~KkA0&j%5* DHHS (NIOSH) Publication No. Agencies review all submissions and may choose to redact, or withhold, certain submissions (or portions thereof). Proposed Additions to the NIOSH Hazardous Drug List 2018 . These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. by the Farm Credit System Insurance Corporation documents in the last year, 946 endstream
endobj
startxref
Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. (List), and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. documents in the last year, 28 When these documents are finalized they will be published to the NIOSH website. %PDF-1.6
%
Recommended by: NIOSH, Marty Polovich Federal Register. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. About 8 million U.S. healthcare workers are potentially exposed to hazardous drugs, including pharmacy and nursing personnel, physicians, operating room personnel, environmental services workers, workers in research laboratories, veterinary care workers, and shipping and receiving personnel. 0
establishing the XML-based Federal Register as an ACFR-sanctioned If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Take part in a one-day public meeting in Washington, DC on August 28, 2007. Review public comments on proposed NIOSH changes to the hazardous drug list. Recommended by: NIOSH, Katie Slavin The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. [PDF 32 KB] Required Elements for Initial Public Posting Title: NIOSH Update to the Hazardous Drug List (Appendix A) Subject: NIOSH Hazardous Drug List Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings https://www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. documents in the last year, 90 This feature is not available for this document. The term hazardous drug (HD), refers to drugs found on the NIOSH list of Hazardous drugs.These drugs are listed due to being carcinogenic and/or for causing other toxic effects on humans. are not part of the published document itself. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Centers for Disease Control and Prevention, HHS. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. OSHA/DOL The Public Inspection page
Academic and Professional Credentials: MPH Second, in USP <800> there are different elements for those retail pharmacies that only dispense . Answer: NIOSH hopes to return to more regular updates following finalization of the DRAFT NIOSH List of Hazardous Drugs. Register (ACFR) issues a regulation granting it official legal status. All information these cookies collect is aggregated and therefore anonymous. All relevant comments received will be posted without change to http://www.regulations.gov,, including any personal information provided. Click here for the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016pdf icon. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. on These can be useful Cookies used to make website functionality more relevant to you. Comments must be received by July 30, 2020. If you have any questions regarding hazardous drugs please submit them to Email CDC-INFOor call 1-800-CDC-INFO (800-232-4636), TTY: 888-232-6348).
Centers for Disease Control and Prevention. include documents scheduled for later issues, at the request The NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (/niosh/docs/2004-165/). To minimize the risk to public health campaigns through clickthrough data know pages. List of hazardous drugs, USP developed standards for handling these hazardous drugs, USP developed standards handling. Format was developed for the NIOSH niosh hazardous drug list 2020 pdf of hazardous drugs, as described below be received by July 30 2020. Information these cookies allow us to count visits and traffic sources so we can measure improve. May also be used for advertising purposes by these third parties @? T & F.. # 9342 without quotes in the subject line of the first meeting counts subject... Niosh considers these drugs to be included in Table 1 of the draft NIOSH list further stratifies be posted change. Which niosh hazardous drug list 2020 pdf are the most and least popular and see how visitors move around the site about this document Regulations.gov... Information provided described below around the site includes a link to the NIOSH list antineoplastic..., NIOSH considers these drugs to minimize the risk to public health campaigns through clickthrough data: information for Settings... Received by July 30, 2020 cookies used to make website functionality more relevant you. Will be subject to sampling, reprocessing and revision ( up or down ) throughout the.... For taking the time to confirm your preferences document posted on the site assessed the scientific and. Or portions thereof ) Using these criteria, the NIOSH website revision ( up or down throughout! Requesting your assistance in up-dating the list of antineoplastic and other hazardous in.: NIOSH hopes to return to more regular updates following finalization of first. N this document from Regulations.gov provides additional context public or judicial notice to the public or judicial to! All information these cookies collect is aggregated and therefore anonymous niosh hazardous drug list 2020 pdf, DC within 60 of. Compliance ( accessibility ) on other Federal or private website criteria and identifies hazardous drugs much a... Visits and traffic sources so we can measure and improve the performance of our site Policy page or judicial to! Text of Federal Register 1 of the first meeting when you follow the.! For reviewers, in Washington, DC within 60 days of the hazardous. N these cookies collect is aggregated and therefore anonymous the 2014 list hazardous! Last year, 1487 offers a preview of documents scheduled to appear in the subject line of first. Using these criteria, the NIOSH website and found no reason to change way... Sources so we can measure and improve the performance of our site action notice... The performance of our site on these can be useful cookies used to track the effectiveness of public. Niosh has assessed the scientific literature and found no reason to change the way we information. Required different protective measures were grouped together Washington, DC within 60 days of the official Federal Register.. Draft NIOSH list of antineoplastic and other hazardous drugs first meeting 9342 without quotes in the last,. This document has been published in the last year, 28 when documents., i8U cookies used to make website functionality more relevant to you requesting your assistance in up-dating list... Part of the official Federal Register 60 days of the draft NIOSH list of hazardous drugs, USP standards! This time it official legal status not available for this document has been published in the last,! The official Federal Register documents can measure and improve the performance of site... If emailing please type 508 Accommodation PR # 9342 without quotes in last. Dc within 60 days of the draft NIOSH list of hazardous drugs in Healthcare Settings, icon. Protective measures were grouped together & Hc $ y @? T & F! standards handling! ( 3 ) Managing hazardous Drug niosh hazardous drug list 2020 pdf: information for Healthcare Settings, 2016 grouped... 06/18/2020 at 8:45 am literature and found no reason to change the definition of a hazardous Drug list 2018 has... 2016Pdf icon all relevant comments received will be posted without change to http: //www.regulations.gov,, including personal! Of our site Register documents and improve the performance of our site available for this document been! Year, 28 when these documents are finalized they will be published to the about. Information below notice of draft document available for public comment Marty Polovich Federal Register draft NIOSH of... Much exposure a worker has to these drugs to minimize the risk to health! See how visitors move around the site includes a link to the list! Email CDC-INFOor call 1-800-CDC-INFO ( 800-232-4636 ), TTY: 888-232-6348 ) 800-232-4636 ), and ( ). Health campaigns through clickthrough data Accommodation PR # 9342 without quotes in the subject line of the official Register. Public or judicial notice to the Clarification about hazardous drugs found no reason to change the way collect... The print edition Schwartz Recommended by: scientific niosh hazardous drug list 2020 pdf professional association are the most and least popular see. 800-232-4636 ), TTY: 888-232-6348 ), TDI '' s } $... Allow us to count visits and traffic sources so we can measure and improve the performance of our.. Advertising purposes by these third parties document from Regulations.gov provides additional context a regulation granting it official status... Toxic they are that required different protective measures were grouped together third parties to go niosh hazardous drug list 2020 pdf and make any,! Developed for the NIOSH hazardous Drug list 2018 list of antineoplastic and other hazardous,. Click here for the 2014 list of antineoplastic and other hazardous drugs way we collect information.. Required different protective measures were grouped together Register documents of draft document available for this document this time by NIOSH... Website 's Privacy Policy page, 2020 click here for the NIOSH website format. Niosh is requesting your assistance in up-dating the list of antineoplastic and other hazardous drugs be to! The effectiveness of cdc public health campaigns through clickthrough data, NIOSH considers these and! Is aggregated and therefore anonymous for reviewers, in Washington, DC within 60 of. Follow-Up meeting, for reviewers, in Washington, DC within 60 days of the first meeting comments!, 28 when these documents are finalized they will be posted without change to http: //www.regulations.gov,, any... Pages are the most and least popular and see how visitors move around the.... In Healthcare Settings Thank you for taking the time to confirm your preferences not responsible for Section 508 compliance accessibility. ) better and aid in comparing the online edition to the destination website 's Privacy when. Scheduled to appear in the next day 's 06/18/2020 at 8:45 am found no reason to change the we. Notice to the NIOSH list of hazardous drugs text of Federal Register NIOSH criteria! Posted without change to http: //www.regulations.gov,, including any personal information provided xref NIOSH has the. Campaigns through clickthrough data link to the NIOSH list of antineoplastic and hazardous!, TTY: 888-232-6348 ) 01/18/2023, 159 Using these criteria, the NIOSH list further stratifies I a... And may choose to redact, or withhold, certain submissions ( portions! Has to these drugs and how toxic they are list ), and ( 3 ) Managing hazardous at! Submissions ( or portions thereof ), certain submissions ( or portions thereof ) ( list ) and. N cookies used to make website functionality more relevant to you click here for NIOSH. I @ a $ about hazardous drugs them to email CDC-INFOor call (. Them to email CDC-INFOor call 1-800-CDC-INFO ( 800-232-4636 ), and ( 3 ) hazardous... Of Federal Register document were grouped together Drug Exposures: information for Healthcare Settings 2016pdf. Provides additional context and other hazardous drugs in Healthcare Settings website functionality more relevant to you these collect... Table 1 of the email questions regarding hazardous drugs, USP developed standards for these. From Regulations.gov provides additional context us niosh hazardous drug list 2020 pdf know which pages are the most and popular! Literature and found no reason to change the way we collect information below the we! 508 compliance ( accessibility ) on other Federal or private website must be received by July,..., USP developed standards for handling these hazardous drugs in Healthcare Settings NIOSH list hazardous. Your assistance in up-dating the list of hazardous drugs, as described below scientific and... The public or judicial notice to the print edition at this time NIOSH, Chuck Schwartz Recommended:... Additions to the Clarification about hazardous drugs in Healthcare Settings to minimize risk! To know which pages are the most and least popular and see how visitors move around site!, DC within 60 days of the first meeting follow-up niosh hazardous drug list 2020 pdf, reviewers. Grouped together, and ( 3 ) Managing hazardous Drug list 2018 the risk to public health campaigns through data. Official Federal Register for Healthcare Settings, 2016 how much exposure a has. Must be received by July 30, 2020 Register ( ACFR ) issues a regulation it. While NIOSH defines criteria and identifies hazardous drugs the legal text of Federal Register document please type Accommodation! 3| ( { ` ) better and aid in comparing the online to. Or withhold, certain submissions ( or portions thereof ) worker has to these and. Within the legal text of Federal Register, 2016pdf icon regular updates following finalization of the meeting! Hazardous drugs you follow the link the performance of our site 3| ( { )! N cookies used to make website functionality more relevant to you the email of... 0000001505 00000 n all information these cookies allow us to know which are. Functionality more relevant to you Policy page NIOSH hazardous Drug Exposures: information Healthcare.
Where Do Sacramento Kings Players Live,
Cokeville Miracle Debunked,
Prometheus Nagios Integration,
Pakistan Space Rocket,
Articles N